Pilot Study of Idiotype Vaccine and EPOCH-Rituximab Chemotherapy in Untreated Mantle Cell Lymphoma
Latest Information Update: 03 Feb 2023
At a glance
- Drugs Dasiprotimut T (Primary) ; Cyclophosphamide; Doxorubicin; Etoposide; Granulocyte macrophage colony stimulating factor; Prednisone; Rituximab; Vincristine
- Indications Mantle-cell lymphoma
- Focus Therapeutic Use
- 17 Jun 2021 Status changed from active, no longer recruiting to completed.
- 17 Jun 2021 Status changed from active, no longer recruiting to completed.
- 15 Jun 2021 Planned End Date changed from 1 Jun 2021 to 1 Jun 2022.